A sham-controlled randomized trial demonstrated that pulsed field ablation (PFA) markedly reduced atrial fibrillation (AF) recurrence and burden while significantly improving quality of life and psychological distress compared with a sham procedure in highly symptomatic AF patients. In this single-blind study, 60 patients with severe AF-related quality-of-life impairment were randomized to either PFA or a sham procedure and followed with continuous rhythm monitoring using implantable cardiac monitors. After 6 months, AF recurrence occurred in only 6.7% of patients treated with PFA versus 83.3% in the sham group. Quality-of-life scores improved dramatically with PFA, increasing by nearly 44 points compared with 11 points in the sham group. AF burden was also substantially lower after PFA, and patients experienced significantly greater reductions in anxiety and depression symptoms. These findings provide strong evidence that the clinical and psychological benefits of AF ablation extend well beyond placebo effects, confirming PFA as an effective treatment for symptomatic AF. Source: https://www.ahajournals.org/
A French prospective cohort study found that higher exposure to preservative food additives commonly used…
Coronary microvascular dysfunction (CMD) was common in patients undergoing invasive coronary angiography and was associated…
A US prospective real-world study of 357 adults with Irritable Bowel Syndrome (IBS) found that…
A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty…
Accelerometer-derived sleep-wake cycle patterns were associated with a higher risk of future dementia and modestly…
Early initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors after Takotsubo syndrome was associated with significantly lower…
This website uses cookies.